Principia SGR’s Principia Health Fund Acquires 70% of the Trifarma Pharmaceutical Group - McDermott Will & Emery

Principia SGR’s Principia Health Fund Acquires 70% of the Trifarma Pharmaceutical Group

Overview


Ettore Scandale was legal advisor to healthcare sector investor Principia SGR as its Principia Health fund purchased 70% of Trifarma, an Italian producer and marketer of active pharmaceutical ingredients.